Breast Ultrasound Market Size & Growth Forecast 2026–2035, By Segments (Product, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Breast Ultrasound Market size stood at USD 2.48 Billion in 2025 and is predicted to grow at a 14% CAGR from 2026 to 2035, reaching USD 9.19 Billion by 2035. The industry revenue for 2026 is calculated at USD 2.79 billion.
Get more details on this report
Request Free Sample ReportBreast Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 37.84% market share in 2025, supported by advanced diagnostic imaging infrastructure, established screening pathways, and routine ultrasound use across hospitals and imaging centers.
- Asia Pacific is expected to expand at a 15.68% CAGR as diagnostic access improves, hospital capacity grows, and ultrasound adoption increases across routine breast screening and follow-up care.
Segment Momentum
- ABUS accounted for 62.18% of the market in 2025 by delivering standardized image acquisition, consistent workflows, and reliable examinations that support efficient screening and diagnostic imaging across healthcare facilities.
- Diagnostics Imaging Laboratories are expanding fastest as demand grows for specialized imaging services offering streamlined workflows, higher imaging throughput, appointment efficiency, and dedicated diagnostic environments.
Market Expansion Drivers
- Rising breast cancer incidence and screening awareness driving diagnostic imaging demand.
- Growing adoption of automated breast ultrasound and AI-enabled imaging systems.
- Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), FUJIFILM Holdings Corporation (Japan), SuperSonic Imagine SA (France), Delphinus Medical Technologies, Inc. (United States), Fukuda Denshi Co., Ltd. (Japan), Lunit Inc. (South Korea).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Rising breast cancer incidence, combined with stronger public awareness of early detection, is increasing the number of women entering diagnostic pathways that require follow-up imaging after routine screening or clinical examination. In the breast ultrasound market, this translates into higher procedure volumes for lesion characterization, dense breast evaluation, and supplemental imaging when mammography findings are inconclusive. Screening campaigns, physician recommendations, and more proactive patient behavior are reinforcing market demand by moving ultrasound from an occasional diagnostic tool to a more routinely used part of breast assessment, particularly in settings where clinicians need a radiation-free, accessible modality to support timely decisions.
Growing adoption of automated breast ultrasound and AI-enabled imaging systems
Growing adoption of automated breast ultrasound and AI-enabled imaging systems is reshaping purchasing decisions by addressing two persistent constraints in the breast ultrasound market: operator dependence and workflow variability. Automated platforms make image acquisition more standardized, which is especially valuable for dense breast assessment and for providers seeking more consistent exam quality across sites and technicians. AI-enabled tools strengthen market development by supporting image interpretation, prioritizing suspicious findings, and reducing reading burden, making ultrasound more scalable for higher screening volumes and more attractive to health systems investing in reproducible, technology-assisted breast imaging pathways.
Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers
Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers is increasing market penetration by bringing breast assessment closer to patients who may face delays in hospital-based imaging access. In the breast ultrasound market, This trend supports demand for compact, efficient systems that can be deployed in decentralized care settings where rapid triage, same-visit evaluation, and shorter referral cycles matter most. As providers build service models around convenience and faster diagnostic turnaround, ultrasound becomes a practical frontline modality for evaluating palpable abnormalities and follow-up findings without the infrastructure demands associated with larger imaging platforms.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising breast cancer incidence and screening awareness driving diagnostic imaging demand | 2.20% | High | North America, Europe | High | Near Term |
| Growing adoption of automated breast ultrasound and AI-enabled imaging systems | 2.00% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers | 1.60% | Moderate | Asia Pacific, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional share of the breast ultrasound market in 2025, accounting for 37.84% share. This position is supported by broad access to diagnostic imaging infrastructure, established breast cancer screening and follow-up pathways, and routine use of ultrasound as a complementary tool in evaluating dense breast tissue and suspicious findings. Market activity is further supported by the region’s ability to integrate newer ultrasound systems into hospital, imaging center, and outpatient workflows, which helps maintain steady procedure volumes and replacement demand.
Asia Pacific is projected to expand at a 15.68% CAGR over the forecast period in the breast ultrasound market, driven by rising access to diagnostic services and increasing use of imaging in breast health assessment across developing and developed healthcare systems in the region. Growth is being accelerated by the practical need for scalable, non-invasive imaging tools that can be deployed across a wider range of care settings, alongside ongoing expansion of hospital capacity and diagnostic networks. As more patients enter formal screening and diagnostic pathways, ultrasound adoption is increasing in everyday clinical practice for both initial assessment and follow-up imaging.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic SupportGermany emphasizes breast ultrasound as an important complementary imaging modality, particularly for patients requiring additional diagnostic evaluation. Investments are directed toward high-resolution systems and efficient integration within hospital imaging departments.
France 🇫🇷
Structured Diagnostic PathwaysFrance utilizes breast ultrasound as part of coordinated diagnostic pathways that support comprehensive breast care. Demand is centered on systems that improve examination efficiency and provide reliable imaging for supplemental assessments.
Italy 🇮🇹
Expanding Imaging AccessibilityItaly is focusing on improving access to breast imaging services through broader deployment of ultrasound equipment across healthcare settings. Providers are seeking versatile systems that support both routine examinations and specialized diagnostic requirements.
Japan 🇯🇵
High-Resolution Screening ToolsJapan is prioritizing advanced breast ultrasound technologies that enhance screening accuracy and support dense breast assessment. Healthcare facilities continue to adopt compact and high-performance systems suited to routine diagnostic workflows.
South Korea 🇰🇷
Technology-Driven ScreeningSouth Korea's breast ultrasound market is characterized by rapid adoption of technologically advanced imaging platforms. Providers are incorporating artificial intelligence and improved visualization tools to strengthen diagnostic confidence and patient management.
United States 🇺🇸
Advanced Imaging IntegrationThe U.S. breast ultrasound market is increasingly focused on integrating advanced imaging technologies into screening and diagnostic pathways. Healthcare providers are adopting systems with improved image quality and workflow capabilities to support early detection initiatives.
Segment Leadership and Growth Trends
Breast Ultrasound Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAutomated Breast Ultrasound (ABUS) held a 62.18% share of the breast ultrasound market in 2025, making it the leading product segment. its position is maintained through the practical value of standardized image acquisition and workflow consistency, which are especially important in settings that require repeatable breast imaging and efficient handling of patient volume. In the breast ultrasound market, ABUS benefits from its ability to support more uniform examinations than operator-dependent alternatives, helping providers maintain reliability across screening and diagnostic use.
Conventional Breast Ultrasound (CBUS) is emerging as the fastest-growing product segment in the breast ultrasound market because it remains highly adaptable in day-to-day clinical practice. Its growth is backed by the need for real-time assessment during breast examinations, where clinicians often require immediate image interpretation and targeted evaluation. Compared with automated systems, CBUS gains momentum from its flexibility in addressing varied patient presentations and its practical fit in facilities that prioritize direct clinician control during imaging procedures.
End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostics Imaging Laboratories (Fastest-Growing Segment)
By 2025, hospitals accounted for a 51.41% share of the breast ultrasound market, establishing them as the largest end-use segment. This leading share is backed by the concentration of breast imaging services within hospital settings, where patients can access ultrasound as part of broader diagnostic pathways and coordinated care. Hospitals maintain their position in the breast ultrasound market because they manage a steady flow of patients requiring integrated imaging, follow-up evaluation, and access to multidisciplinary clinical resources.
Diagnostics Imaging Laboratories are the fastest-growing end-use segment in the breast ultrasound market, influenced by rising demand for specialized and more focused imaging services. Their momentum comes from practical operating models built around imaging throughput, appointment efficiency, and dedicated diagnostic workflows, which can make them attractive relative to broader hospital environments. As breast imaging demand expands, these laboratories are gaining traction by offering streamlined access to ultrasound examinations in settings designed specifically for diagnostic imaging delivery.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Conventional Breast Ultrasound (CBUS), Automated Breast Ultrasound (ABUS) | Automated Breast Ultrasound (ABUS) | Conventional Breast Ultrasound (CBUS) |
| End Use | Hospital, Diagnostics Imaging Laboratories, Others | Hospital | Diagnostics Imaging Laboratories |
Competitive Landscape and Market Positioning
1. GE HealthCare Technologies Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. Siemens Healthineers AG (Germany)
4. Canon Medical Systems Corporation (Japan)
5. Hologic Inc. (United States)
6. FUJIFILM Holdings Corporation (Japan)
7. SuperSonic Imagine SA (France)
8. Delphinus Medical Technologies Inc. (United States)
9. Fukuda Denshi Co. Ltd. (Japan)
10. Lunit Inc. (South Korea)
The breast ultrasound market is advancing with improvements in imaging resolution and diagnostic precision. Innovation in portable and high-frequency ultrasound systems is enhancing clinical usability. Continuous development in imaging algorithms is supporting more accurate and early-stage detection capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| iSono Health | Apr-26 | iSono Health commercially launched ATUSA, an FDA-cleared, wearable 3D breast ultrasound system. This automated platform is designed to decentralize breast imaging by reducing reliance on specialized sonographers and conventional hospital-based infrastructure, representing a significant shift toward portable, high-throughput breast cancer screening accessibility. |
| RadNet | Apr-26 | RadNet, through its DeepHealth subsidiary, acquired See-Mode Technologies to incorporate AI-powered ultrasound imaging solutions into its clinical operations. This strategic acquisition enhances RadNet's diagnostic capabilities and strengthens its position in the competitive AI-driven medical imaging market, facilitating more efficient ultrasound interpretation and clinical workflow integration. |
| GE HealthCare | Apr-26 | GE HealthCare launched the Ivenia ABUS Premium, an AI-enhanced automated breast ultrasound system. The platform is engineered to optimize supplemental breast screening workflows, improving diagnostic throughput and imaging consistency. This release underscores the company’s strategic commitment to leveraging artificial intelligence to address clinical inefficiencies in large-scale breast cancer screening programs. |
| Samsung Medison | May-26 | Samsung Medison formed a strategic partnership with HistoSonics to integrate its R20 ultrasound system with the Edison platform. This collaboration enables seamless connectivity between diagnostic imaging and therapeutic ultrasound technologies, marking a strategic expansion for Samsung into the emerging field of ultrasound-guided, non-invasive therapeutic interventions. |
| iCAD | Apr-26 | iCAD entered a strategic reseller partnership with Koios Medical to integrate AI-driven diagnostic technologies across mammography and ultrasound platforms. This initiative creates a multi-modality breast cancer detection ecosystem, allowing for more cohesive diagnostic workflows that improve clinical decision-making from initial screening through to final assessment. |
| BeamWorks | Apr-26 | BeamWorks secured regulatory approval in South Korea for its CadAI-B software, an AI-assisted diagnostic tool for breast cancer detection. The regulatory clearance facilitates the commercial deployment of advanced, software-based diagnostic support in clinical environments, contributing to the broader market trend toward AI-augmented breast imaging and improved diagnostic precision. |
| USM Hospital | Apr-26 | USM Hospital deployed GE HealthCare’s Invenia ABUS 2.0, marking the first installation of this automated breast ultrasound system on Malaysia’s east coast. This strategic infrastructure investment significantly upgrades the region’s breast cancer screening capacity, reflecting a broader trend of expanding access to advanced, standardized automated ultrasound technology in emerging healthcare markets. |
| Lily MedTech | Apr-26 | Lily MedTech announced advancements in its breast imaging portfolio, specifically focusing on ultrasound mammogram technology. This development aims to enhance early-stage breast cancer detection by utilizing ultrasound-based screening as a primary modality, challenging conventional diagnostic paradigms and signaling a potential shift in long-term breast imaging clinical practices. |
| Hologic, Inc. | Nov-23 | Hologic, Inc. introduced Genius AI Detection 2.0, an advanced software solution designed to improve breast cancer detection rates while simultaneously reducing false-positive markings. The release serves as a strategic update to the company's AI-driven diagnostic portfolio, improving the accuracy of clinical screening workflows and enhancing the competitive utility of its imaging hardware. |
| Hologic, Inc. | Sep-23 | Hologic, Inc. partnered with Bayer to jointly develop and distribute contrast-enhanced mammography (CEM) solutions globally. This strategic alliance combines Hologic’s imaging hardware expertise with Bayer’s contrast media capabilities, aiming to expand diagnostic options for breast cancer detection and address the specific imaging needs of patients with dense breast tissue. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Breast Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Breast Ultrasound Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the breast ultrasound market?
What is the anticipated CAGR of the breast ultrasound industry?
How are automation and AI influencing purchasing decisions in the breast ultrasound market?
Why is point-of-care imaging accelerating growth in the breast ultrasound market?
Why is Automated Breast Ultrasound (ABUS) the largest product segment in the breast ultrasound market?
Why are Diagnostics Imaging Laboratories the fastest-growing end-use segment in the breast ultrasound market?
Why does North America lead the breast ultrasound market?
What factors are accelerating breast ultrasound market growth in Asia Pacific?
Who holds a significant market share in the breast ultrasound landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization